Commentary: Insulin-Induced Lipohypertrophy Treated With Liposuction: A Review of Case Reports

Abstract

Get full access to this article

View all access options for this article.

References

Mangan

Levine

Barrett

. Insulin-induced lipohypertrophy treated with liposuction: a review of case reports. Plastic Surg. 2023. doi:https://doi.org/10.1177/22925503231198095

Saeedi

Petersohn

Salpea

, et al.; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:https://doi.org/10.1016/j.diabres.2019.107843

Blanco

Hernández

Strauss

Amaya

. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39:445–453. doi:https://doi.org/10.1016/j.diabet.2013.05

Hoyos

Millard

. VASER-assisted high-definition liposculpture. Aesthet Surg J. 2007;27:594–604. doi:https://doi.org/10.1016/j.asj.2007.08.007

Ciudad

Manrique

Bustos

, et al. Single-stage VASER-assisted liposuction and lymphatico-venous anastomoses for the treatment of extremity lymphedema: a case series and systematic review of the literature. Gland Surg. 2020;9(2):545–557. doi:https://doi.org/10.21037/gs.2020.01.13

Gibas-Dorna

Szulińska

Turkowski

, et al. The effect of VASER abdominal liposuction on metabolic profile in overweight males. Am J Mens Health. 2017;11(2):284–293. doi:https://doi.org/10.1177/1557988316674841